Have you ever prescribed a proton pump inhibitor for a bleeding patient and wondered why the infusion should run for 72 hours? Or why patients with atrial fibrillation are anticoagulated rather than put on antiplatelets? As it turns out, there is evidence for (most of) what we do, and this site aims to present it to you.
Many of us like to scan abstracts because they are a concise summary of the study being presented. However, smaller nuances like certain populations in whom the trial results may not be applicable are usually not immediately appreciable. Here, we summarise the study population and methods concisely, so that you can decide yourself how a certain study applies to your own patients.
Many practice guidelines from around the world are based on some of the trials which are presented here. Key findings and conclusions are highlighted, and their relevance to clinical practice today explained.
No study is perfect. Certain studies have more glaring flaws than others, or confounders which may or may not be relevant to clinical practice. Still, caveats are essential to bear in mind, so as to avoid errors in generalising study conclusions.